MitraClip in Acute Mitral Regurgitation
European Registry of MitraClip in Acute Myocardial Infarction
Sponsor: Abbott Medical Devices
A observational or N/A phase clinical study on Acute Myocardial Infarction and Mitral Regurgitation, this trial is completed. The trial is conducted by Abbott Medical Devices and has accumulated 12 data snapshots since 2017. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Apr 2022 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Nov 2021 — Apr 2022 [monthly]
Active Not Recruiting
-
Jan 2021 — Nov 2021 [monthly]
Active Not Recruiting
▶ Show 7 earlier versions
-
Mar 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Feb 2020 — Mar 2020 [monthly]
Active Not Recruiting
-
Aug 2019 — Feb 2020 [monthly]
Active Not Recruiting
Status: Enrolling By Invitation → Active Not Recruiting
-
Dec 2018 — Aug 2019 [monthly]
Enrolling By Invitation
-
Jun 2018 — Dec 2018 [monthly]
Enrolling By Invitation
-
Apr 2018 — Jun 2018 [monthly]
Enrolling By Invitation
Phase: NA → None
-
May 2017 — Apr 2018 [monthly]
Enrolling By Invitation NA
First recorded
Jan 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott Medical Devices
- Fundación Investigación Sanitaria en León
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.